Business, Companies, coronavirus, earnings, Gland Pharma

Gland Pharma | Representative image

Drug maker Gland Pharma on July 21 reported a 12 percent year-on-year increase in net profit to Rs 350.7 crore in the quarter ended June 30. The growth in net profit was led by a mix of new products and volume growth in existing products, the company said.

Gland Pharma, owned by China’s Fosun Pharma, in the corresponding period of previous the year posted a net profit of Rs 313.6 crore. Revenue from operations rose 31 percent YoY to Rs 1,153.9 crore in Q1FY22 versus Rs 884.2 crore in Q1FY21.

On a quarter-on-quarter (QoQ) basis, the net profit rose 35 percent and revenues by 30 percent.

The earnings before interest, tax, depreciation and ammortisation (EBITDA) margin stood at 41 percent in Q1FY22.

Gland’s key markets –the US, Canada, Europe and Australia

— registered a growth of 16 percent and accounted for 61 percent of total revenue during Q1FY22.

“This performance is driven by growth of key products like Micafungin, Enoxaparin, Heparin, Dexmedetomidine and new product launches,” the company said.

India accounted for 20 percent or Rs 227 crore of Q1FY22 revenue, which witnessed a 77 percent Y-o-Y growth for the quarter.

“To support the domestic market requirement during the second wave of COVID-19, the company ramped up supply of essential drugs like Remdesivir and Enoxaparin,” Gland said.

The rest of the world markets have seen a robust growth of 51 percent in line with the company’s increased focus on geographic expansion.

“This is driven by increased penetration by forming new partnerships in various countries,” Gland said.

The total capex incurred during the quarter ended June 30, 2021, was Rs 1,857 million.

“Our execution capability, be it uninterrupted commercial supplies, project commissioning or new product launches, is what underpins our strong performance in this quarter,” said Srinivas Sadu, MD & CEO of Gland Pharma.

“It was an important milestone for the company to launch our first set of Penem products for the US market during the quarter,” Sadu added.

Gland said a dedicated suite for vaccine drug product fill-finish is now ready for commercial production, while the tech transfer for the drug substance manufacturing is ongoing.


Japan travel news, japan travel guides, japan holiday destinations and japan reviews

LATEST NEWS

NEWS RELATED

Torrent Gas plans Rs 10,000 crore capex in 5 years; sets up 25 CNG stations in Chennai

Representative image Torrent Gas, part of the USD 3 billion Torrent Group, has drawn up a Rs 10,000 crore capital expenditure plan spread over the next five years including Rs 5,000 crore investment in Tamil Nadu, a top company official said on Tuesday. The company earlier in the day launched…

Read more: Torrent Gas plans Rs 10,000 crore capex in 5 years; sets up 25 CNG stations in Chennai

Adani Ports raises $750 million from global markets

The amount to be disbursed by NHAI would provide a liquidity breather for the projects. Adani Ports and Special Economic Zone Ltd (APSEZ) has raised USD 750 million (around Rs 5,582 crore) through issues of bonds, including a 20-year unsecured bond issue, from the global markets. The company claimed that…

Read more: Adani Ports raises $750 million from global markets

Cairn arbitration: Govt confirms French court order against Indian assets

(File image: Cairn Energy) The government on Tuesday confirmed that a French court has ordered the freezing of certain Indian assets in Paris on a petition by Britain’s Cairn Energy, which is seeking to recover USD 1.72 billion from New Delhi after winning an arbitration against retro tax. Minister of…

Read more: Cairn arbitration: Govt confirms French court order against Indian assets

Retailers start expansion as COVID-19 second wave ebbs; focus on high-street locations, smaller towns

Representative image Retailers across segments in India are on an expansion spree as the second wave of the COVID-19 pandemic subsides. While some retailers are implementing plans that had to be stalled due to curbs, others are scouting for new locations to make the most of a drop in rentals…

Read more: Retailers start expansion as COVID-19 second wave ebbs; focus on high-street locations, smaller towns

Maruti Suzuki India partners with Savitribai Phule Pune University to train youth in auto retail

Representative Image The country’s leading car maker Maruti Suzuki India on Tuesday said it has partnered with Savitribai Phule Pune University, Maharashtra, to train the youth in automobile retail. A customised three-year “Bachelor of Vocational Studies in Retail Management” course will be offered to students by the university with support…

Read more: Maruti Suzuki India partners with Savitribai Phule Pune University to train youth in auto retail

19 drug cocktails approved pre-1988 come under fresh review

Medicines (Representative image) Nineteen fixed dose combinations (FDC) drugs that were exempted from government ban in 2016 as they were approved prior 1988, will be coming come under fresh review for safety and efficacy. An expert committee appointed by the Central government will check if these drug cocktails have any…

Read more: 19 drug cocktails approved pre-1988 come under fresh review

ABB to divest Mechanical Power Transmission division to RBC Bearings for $2.9 billion

Representative image Swiss engineering major ABB on Tuesday said it has signed a pact to divest Mechanical Power Transmission division (Dodge) to RBC Bearings for USD 2.9 billion. The transaction will create a manufacturer of highly engineered, performance-critical bearings and motion control components, ABB said in a statement. The transaction…

Read more: ABB to divest Mechanical Power Transmission division to RBC Bearings for $2.9 billion

Axis Bank buys 5.55% stake in financial technology firm IBBIC

Axis Bank on Tuesday said it has bought 5.55 percent stake in financial technology firm IBBIC. The bank has subscribed to 50,000 equity shares of face value of Rs 10 each fully paid up of IBBIC Private Ltd (IBBIC) for a consideration of Rs 10 per equity share constituting 5.55…

Read more: Axis Bank buys 5.55% stake in financial technology firm IBBIC

Tata Communications unveils IZO financial cloud platform in India

Skoda to expand presence to100 cities in India by next month

Tata Motors rolls out 10,000th unit of new Safari

Tata Power distribution arm in Odisha ties up with CSCs to facilitate online bill payments in rural areas

Amazon eyes potential stake in Indian film, media businesses; Inox denies report

DLF's Q1 sales bookings jump nearly 7-fold to Rs 1,014 crore despite second wave of COVID-19

Auto firms mull another price hike as soaring input costs erode margins

Tesla quarterly profits top $1 billion for 1st time

OTHER NEWS